companies

medicine

Sports Medicine Market Analysis by Applications, End-Users, Top Companies, Future Growth Opportunities, Product Type, Global Forecast To 2020

The MarketWatch News Department was not involved in the creation of this content.

Japan, Japan, Wed, 02 Dec 2020 14:20:31 / Comserve Inc. / — Over the years, the sports medicine market has witnessed various technological advancements made to ensure and provide better recovery and rehabilitative measures for injuries caused during sports or physical activities.

The sports medicine market comprises products and devices used by professional or non-professional athletes or sportspersons to prevent and protect themselves from injuries as well as devices that enhance performance. The sports medicine products play an important role in the rehabilitation, recovery, protection, endurance, and monitoring of athletes while playing sports. Over the years, the sports medicine market has witnessed various technological advancements made to ensure and provide better recovery and rehabilitative measures for injuries caused during sports or physical activities.

These advancements have led to the development of new products and therapies to treat sports injuries. Various market players are focusing on the introduction of newer products and treatment options for sports injuries. A number of key players are competing to secure larger shares of the market by launching new products. Arthrex, Inc. (U.S.), Smith & Nephew PLC (U.K.), DePuy Synthes Companies (U.S.), Stryker Corporation (U.S.), and CONMED Corporation (U.S.) are the top five players of this market

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-61031

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

In 2015, the body reconstruction & repair products segment is expected to account for the largest share of the global sports medicine market, by product, while the knee injuries segment is expected to account for the largest share of the sports medicine market, by application.

In 2015, North America is expected to account for the largest share of the global sports medicine market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). In the coming years, the sports medicine market is expected to witness the highest growth rate in the Asia-Pacific region, with emphasis on India, China, and Japan. The entry of international players, increasing government initiatives, and rising awareness regarding sports medicine in emerging nations like India and China are expected to drive the market in these regions.

The sports medicine market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various growth strategies (agreements, partnerships, joint ventures, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market

Read More
fitness

Newswire Supports Fitness Companies as They Educate Americans on Wellness During Unprecedented Pandemic – Press Release

With gyms and health centers facing difficulties this winter, many fitness leaders are turning toward online content to educate both businesses and individuals.


NEW YORK – November 17, 2020 – (Newswire.com)

​Newswire’s Earned Media Advantage Guided Tour has acted as a reliable resource for fitness companies that are looking to stay in front of their target audience with educational material and virtual workouts. This will be increasingly valuable with the American people likely heading into another lockdown period this winter; leaders in the fitness industry have already begun to pivot their communications strategies to remain relevant. 

“Information sessions and online content will be crucial for fitness companies in the months to come, as tactics related to virtual experiences and in-person safety will give gyms, yoga studios, and wellness centers a chance to stay in business during the unpredictable winter months,” said Charlie Terenzio, Newswire’s VP Earned Media Advantage Business. 

This past summer, many gyms across the U.S. were allowed to re-open at limited capacities. This provided fitness enthusiasts with the opportunity to get back to working out in a public setting, and it provided gym owners with the chance to generate revenue after an extended period of forced closures. 

Pamela Kufahl, Content Director for Club Industry, noted in a recent article how UKactive, Europeactive, IHRSA, FIT Summit, and Mercado Fitness will have speakers present during the global Future of Fitness virtual event. The sessions will feature discussions regarding the challenges that the fitness industry faces as a whole, and speakers will provide insight to businesses looking to survive and thrive in the months to come. 

Newswire’s Earned Media Advantage Guided Tour Market Builder supplies fitness professionals and C-suite executives with the ability to launch educational content campaigns to help position their brand as an industry leader for trending approaches to modern fitness. 

Fitness companies have used Newswire’s EMA GT Market Builder to educate fellow executives as the industry looks to survive as a whole. The platform has also been effective in distributing relevant information regarding new mobile apps and at-home workouts for gym-goers that may be reluctant to exercise in public spaces as the pandemic progresses this winter.  

Learn how Newswire’s Earned Media Advantage Guided Tour Market Builder can help your brand gain a competitive advantage through industry leadership today.

About Newswire

Newswire delivers press release and multimedia distribution software and services (SaaS) that empower the Earned Media Advantage: greater brand awareness, increased traffic, greater return on media and marketing communications spend and the competitive edge. With over a decade of experience, Newswire continues to provide its customers with the ability to deliver the right message to the right audience at the right time through the right medium.

To learn more about how Newswire can help you, visit http://www.newswire.com.

Contact Information

Charlie Terenzio
VP of Earned Media Advantage Business 
Newswire
Office: 813-480-3766
Email: [email protected]

Press Release Service
by
Newswire.com

Original Source:

Newswire Supports Fitness Companies as They Educate Americans on Wellness During Unprecedented Pandemic

Read More
fitness

Pacific Northwest fitness, outdoor companies thrive in the pandemic, but will their sudden success endure?

After suffering its worst year ever in 2019, Nautilus is enjoying its best in 2020.

The Vancouver maker of home fitness products enjoyed record operating profits and a huge, 152% increase in sales in its third quarter, the company announced Monday. Its stock had leapt twentyfold in a matter of months.

What happened? Strangely enough, the global pandemic.

The virus that has crippled portions of the economy has created unprecedented opportunities in others. While hotels, countless bars and restaurants and even the nation’s airlines struggle to stay aloft, purveyors of home fitness products, outdoor gear, bicycles and boats are struggling to meet demand.

Consumers are looking for ways to stay fit and active that also offer some safety from the coronavirus, said Matt Powell, a prominent analyst of consumer retail trends. Companies that fulfill both needs are enjoying “insanely good times,” he said.

It’s not just home fitness companies like Nautilus. Millions of stir-crazy Americans are desperate to get out of the house and yet stay safe.

“If you’re not going to Italy or Croatia, what are you going to do?” said Jess Turner of the Outdoor Recreation Roundtable in Washington, D.C. “People chose camping, they chose the outdoors. It’s a fun and safe way to socialize with your friends and control your environment.”

The question now is whether these pandemic beneficiaries can transform their sudden burst of success into something durable. Monday’s news that a prospective vaccine may be nearly ready, and that it may be far more effective than many observers anticipated, sent the Dow soaring more than 800 points in one day – but pulled Nautilus down more than 20%.

Jim Barr, Nautilus’ CEO, argues that the pandemic has changed the fitness business much like it has changed the commercial real estate business. Working remotely has shown everyone that a traditional office is not absolutely necessary. Closures of commercial gyms have shown people that working out at home is a viable option.

“We have surveys in which 25 to 30% of people say they’ll never go back to a gym,” Barr said.

The Vancouver company’s dramatic turnaround seemed highly unlikely just a year ago. The company lost $92.8 million in 2019. Sales declined 21%, to $309 million, its lowest total in six years.

From the outside, the company looked out of ideas, out of momentum and nearly out of money. It had just $11 million in cash on hand, compared to more than $63 million the year before. Barr said the company had missed the trend toward “connected fitness” — digitally enabled equipment that links users to coaches or other users.

Peloton’s rise to the top of the market was largely due to its pioneering role in connected products, with people meeting up online to ride stationary bikes much as gamers meet over the internet to find Xbox opponents.

Then came the virus and the coronavirus recession. Nautilus’ stock hit a low of $1.20 a share on March 23.

The company’s phones lit up as the pandemic

Read More
fitness

Global Fitness Tracker Market 2024: Size, Key Companies, Trends, Growth and Regional Forecasts Research

The MarketWatch News Department was not involved in the creation of this content.

Nov 10, 2020 (The Expresswire) —
The report outlines the competitive framework of the “Fitness Tracker Market” industry detailing the SWOT analysis and Fitness Tracker market share dominance of the prominent players. Global Fitness Tracker Market Report has released a new research Analysis and forecast 2019-2024 comprehensive of one or more factors covering regional opportunities, application landscape, product demand, Fitness Tracker market trends and end-use portfolio of the industry over the forecast timeframe 2024

Get a Sample Copy of the Report at – https://www.absolutereports.com/enquiry/request-sample/13902685

● Fitness Tracker is a small and stylish sports fitness accessories, it is based on advanced MEMS technology to not only measure the daily fitness activities consumed by the heat, the number of steps and distance, and can monitor your sleep quality. ● The global Fitness Tracker industry mainly concentrates in USA, Europe, China and Japan. The global leading players in this market are Apple, Epson, Garmin, Jawbone, Misfit, Nike, XiaoMi, Fitbit, Under Armour, Samsung. ● Currently, a major challenge affecting the market growth is the limitation of downstream market. As large demand of healthy products at home and abroad, many companies began to enter the field. Currently, the Fitness Tracker industry is not only begin to transit to Fitness Tracker products, while still extend in the resource-rich land and downstream industry chain. ● Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this area, the future will still have more new investment enter the field. In the next five years, the consumption volume will keep stable increasing, as well as the consumption value.4

The Fitness Tracker Market report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

● Apple ● Epson ● Garmin ● Jawbone ● Misfit ● Nike ● XiaoMi ● Fitbit ● Under Armour ● Samsung

Fitness Tracker Market by Types

● Basic ● Smart

Fitness Tracker Market by Applications

● Specialist Retailers ● Factory outlets ● Internet sales ● Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.,

● United States ● Canada ● Mexico ● Brazil ● APAC ● ………………

Inquire or share your questions if any before the purchasing this report –https://www.absolutereports.com/enquiry/pre-order-enquiry/13902685

Detailed TOC of Global Fitness Tracker Market Growth 2019-2024

Table of Contents

Global Fitness Tracker Market Forecast 2019-2024

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Fitness Tracker Market Industry

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Fitness Tracker F 2014-2024

2.1.2 Fitness Tracker Consumption CAGR by Region

2.2 Fitness Tracker Segment by Type

2.2.1 Type 1

2.2.2 Type 2

2.3 Fitness Tracker Consumption by Type

2.3.1 Global Fitness Tracker Consumption Market Share by Type (2014-2019)

2.3.2 Global Fitness Tracker Revenue and

Read More
medicine

Medicine Companies Report COVID Vaccine Effectiveness

The MarketWatch News Department was not involved in the creation of this content.

Nov 09, 2020 (Baystreet.ca via COMTEX) —
U.S. pharmaceutical giant Pfizer (NYSE:PFE) and German biotech firm BioNTech (NASDAQ:BNTX) announced Monday their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, hailing the development as “a great day for science and humanity.”

It comes as drugmakers and research centers around the world scramble to deliver a safe and effective vaccine in an attempt to bring an end to the coronavirus pandemic that has claimed over 1.25 million lives worldwide.

Scientists are hoping for a coronavirus vaccine that is at least 75% effective, while White House coronavirus advisor Dr. Anthony Fauci has previously said one that is 50% or 60% effective would be acceptable.

The results were based on the first interim efficacy analysis conducted by an external and independent Data Monitoring Committee from the phase three clinical study. The independent group of experts oversees U.S. clinical trials to ensure the safety of participants.

The analysis evaluated 94 confirmed Covid-19 infections among the trial’s 43,538 participants. Pfizer and BioNTech said the case split between vaccinated individuals and those who received a placebo indicated a vaccine efficacy rate of above 90% at seven days after the second dose.

It means that protection from Covid-19 is achieved 28 days after the initial vaccination, which consists of a two-dose schedule.

The final vaccine efficacy percentage may vary, however, as safety and additional data continue to be collected.

PFE shares grew $2.31, or 6.4%, to $38.71, while those for BNTX climbed $10.78, or 11.7%, to $102.78.

COMTEX_374175609/2559/2020-11-09T11:00:35

Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Source Article

Read More
fitness

Connected Fitness Companies Chart New Course

It has been a good year for connected fitness company Peloton. For Q3 it saw sales grow by 232 percent to $757.9 million from $228 million a year ago. Analysts had been forecasting sales revenue of  $748.1 million.

That massive bump was driven by fitness-oriented consumers who have increasingly turned to connected bikes and treadmills to rebuild their exercise routines at home in a world where going to the gym feels a bit like a risk to one’s health.

It’s growth Peloton has been reporting throughout 2020 as the pandemic has raged on, and it is a trend the firm is forecasting to continue. It is officially expecting holiday 2020 to mark its first ever billion-dollar quarter for sales. Good news to be sure, but it’s perhaps a little bit more good news that Peloton can handle. The year has also been marked by soaring sales and difficulty with scale. Delays have plagued consumer orders — delays that will continue to constrain the supply chain for the “foreseeable future,” according to Peloton.

“As we rapidly scale our organization to meet the extraordinary demand for our products, we realize that some of our members have faced extended delays associated with receiving our products or having support requests fulfilled,” CEO John Foley said in a letter to shareholders.

And that extraordinary demand for Peloton has been mirrored by extraordinary demand for a host of connected fitness products from it and other companies. The market is now flooded with smart bikes, smart mirrors, smart rowing machines and treadmills. Individual variations vary, but the emerging class of connected fitness tech generally comes with an embedded screen that allows users to take part in virtual exercise classes with other enthusiasts and upload their fitness data to mark their progress over time.

It’s a segment that once looked like a niche offshoot in the gym-dominated fitness market — but since the outbreak of COVID-19 has become an increasingly attractive segment for startups, investors and even established players drawn to a rapidly growing market.

In July Lululemon announced its intention to purchase connected fitness firm MIRROR for $500 million. MIRROR’s particular specialty was interactive fitness classes proffered via its connected tech — a device that, when turned off, looks like a normal mirror. But when turned on, users can see their reflection and other class participants while working out.

“The acquisition of MIRROR is an exciting opportunity to build upon that vision, enhance our digital and interactive capabilities,” Lululemon CEO Calvin McDonald said in the announcement.

And the consumers’ rapid transition to home-based fitness experiences bolstered by connective tech that virtualizes the group part of the experience is changing more than just the front end of the industry. The supply chain behind the industry is now “doing summersaults,” according to Eric Goldapske, senior director of operations at Horizon Fitness. At an industry event, he said exercise equipment suppliers like himself have had to quickly shift from mostly serving public gyms

Read More
medicine

Personalized Medicine Market 2020: Industry Trends and Growth Rate, Product & Application Segmentation, Key Companies and Regional Analysis by 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 04, 2020 (The Expresswire) —
The report “Personalized Medicine Market” in Global to 2026 – Market Scope, Development, and Predictions offers the most up-to-date industry information on the actual market situation, and future outlook for vision frames and mountings in worldwide.

The research includes historic data from 2020 and forecasts until 2026 which makes the report a valuable resource for industry executives, presentation, sales and product managers, consultants, analysts, and other people looking for key industry data in a readily available document with clearly presented tables and Figures.

Request a sample copy of the report – https://www.absolutereports.com/enquiry/request-sample/16517279

Individualized medication, medication “vary from person to person” , give full consideration to each patient’s genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.

Personalized Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Personalized Medicine business, the date to enter into the Personalized Medicine market, Personalized Medicine product introduction, recent developments, etc.

The Following Manufacturers Are Covered in This Report:

● Abbott Laboratories ● Agilent Technologies ● Amgen ● Astellas Pharma ● Astrazeneca ● Bayer AG ● Celgene Corporation ● Glaxosmithkline Plc ● Illumina ● Johnson and Johnson ● Laboratory Corporation ● Merck ● Novartis AG ● Roche Holding AG ● Siemens AG ● Takeda Pharmaceutical Company Limited

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT – REQUEST SAMPLE

Personalized Medicine Market Breakdown Data by Type

● Personalized Medicine Diagnostics ● Personalized Medical Care ● Personalized Medicine Therapeutics ● Personalized Nutrition and Wellness

Personalized Medicine Market Data by Application

● Oncology ● Central Nervous System (CNS) ● Immunology ● Respiratory ● Other Applications

Inquire Or Share Your Questions If Any Before The Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/16517279

Geographic Segmentation

The report offers exhaustive assessment of different region-wise and country-wise Breast Localization Needles markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Breast Localization Needles market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.

Detailed TOC of Global Personalized Medicine Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key

Read More
medicine

Global Personalized Medicine Markets Report 2020: Focus on Scientific Basis & Technologies and Markets & Companies

The “Personalized Medicine – Scientific & Commercial Aspects” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering.

The concept of personalized medicine described in this report remains the best way to integrate new technologies such as nanobiotechnology for improving healthcare.

Increase in efficacy and safety of treatment by individualizing it has benefits in financial terms. Information is presented to show that personalized medicine will be cost-effective in healthcare systems. For the pharmaceutical companies, segmentation of the market may not leave room for conventional blockbusters but smaller and exclusive markets for personalized medicines would be profitable. Marketing opportunities for such a system are described with market estimates from 2019-2029.

Profiles of 298 companies involved in developing technologies for personalized medicines, along with 583 collaborations are included.

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics,pharmacoproteomics, and metabolomics.

Basic technologies of molecular diagnostics play an important role, particularly those for single nucleotide polymorphism (SNP) genotyping. Biomarkers play an important role in personalized medicine. Diagnosis is integrated with therapy for selection of treatment as well for monitoring the results. There is emphasis on early detection and prevention of disease in modern medicine. Biochip/microarray technologies and next generation sequencing are also important.

Pharmacogenetics, the study of influence of genetic factors on drug action and metabolism, is used for predicting adverse reactions of drugs. Several enzymes are involved in drug metabolism of which the most important ones are those belonging to the family of cytochrome P450. The knowledge of the effects of polymorphisms of genes for the enzymes is applied in drug discovery and development as well as in clinical use of drugs. Cost-effective methods for genotyping are being developed and it would be desirable to include this information in the patient’s record for the guidance of the physician to individualize the treatment.

Pharmacogenomics, a term that overlaps with pharmacogenetics but is distinct, deals with the application of genomics to drug discovery and development. It involves the mechanism of action of drugs on cells as revealed by gene expression patterns. Pharmacoproteomics is an important contribution to personalized medicine as it is a more functional representation of patient-to-patient variation than that provided by genotyping.A ‘pharmacometabonomic’ approach to personalizing drug treatment is also described.

Biological therapies such as those which use patient’s own cells are considered to be personalized medicines. Vaccines are prepared from individual patient’s tumor cells. Individualized therapeutic strategies using monoclonal bodies can be directed at specific genetic and immunologic targets. Ex vivo gene therapy involves the genetic modification of the patient’s cells in vitro, prior to reimplantation of these cells in the patient’s body.

Various technologies are integrated to develop personalized therapies for specific therapeutic areas described in the report. Examples of this are genotyping for drug resistance in HIV

Read More
health

Global Oncolytic Virus Therapy Market 2026 Companies Clinical Trials Insight

Oncolytic Virus Immunotherapy Market Offers US$ 700 Million Opportunity With More Than 125 therapies in Clinical Trials says Kuick Research

DELHI, India, Nov. 02, 2020 (GLOBE NEWSWIRE) — “Global Oncolytic Virus Immunotherapy Market, Dosage, Price & Clinical Trials Outlook 2026” Report Highlights:

  • Global Oncolytic Virus Immunotherapy Market: US$ 700 Million Opportunity

  • Global Oncolytic Virus Immunotherapy Clinical Trials: >125 Therapies In Trials

  • USA Dominates Oncolytic Virus Immunotherapy Clinical Trials: >50 Therapies In Trials

  • Comprehensive Insight on Clinical & Non Clinical Issues Related to Global Oncolytic Virus Immunotherapy Market Development

  • Approved Oncolytic Virus Immunotherapy: 2

  • Global Research Progress & Medical Advancement Insight

  • Imlygic (Talimogene laherparepvec) & Oncorine: Dosage, Price & Patent insight

Download Report: https://www.kuickresearch.com/report-oncolytic-virus-immunotherapy-market-size-sales-clinical-trials-cancer-oncology-melanoma-report-talimogene-laherparepvec-imlygic–oncorine

Recent breakthrough with respect to oncolytic virus therapy in the oncology pharmaceutical industry has set up remarkable achievements in terms of understanding all the important proposed hallmarks for counteracting cancer mechanism of action. The important clinical management terms related with oncolytic virus therapy is believed to be extracting and abolishing all the disadvantages and limitations that were associated with all the commercially available cancer therapies. Certain challenges that were residing in the oncology pharmaceutical industry is estimated to end once the market associated with oncolytic virus therapy comes into full power in terms of financial and commercial availability.

The wide range applications of oncolytic virus therapy with respect to different types of cancers such as melanoma, prostate cancer, breast cancer, ovarian cancer and many others is estimated to deliver a very bulk amount of research and development investment for the future progress of the therapy at global level. The estimated future market competition oncolytic virus therapy is intense as the market is associated with some of the leading drug research and development players, high research marketing as well as a monopoly situation in treating different types of cancers. As per the study conducted for the market, it is estimated that in the next few years, the market will surpass USD 700 Million by 2026.

In a short period of time, oncolytic virus therapy has selectively replaced all the other traditional cancer therapies available for the cancer patients as the therapy is adjoined with large number of innovative principles. Several therapeutic agents under oncolytic virus therapy has entered clinical studies and have specifically proven to be safe and efficient for human use. Although the market is few years old but the related research and development sector as well as future research is believed to make the system functional as well as effective for millions of cancer patients who have been suffering very badly from past few years.

With the arrival of oncolytic virus therapy for the cancer patients, all the barriers that were pursed in the oncology pharmaceutical industry have been overcome promisingly as the therapy has entered and been recognized as a mainstream treatment facility for the clinical management of the cancer cells. The long-term future of the market at global level appears to be developing at a rate that is highly advanced as researchers

Read More
medicine

Global Personalized Medicine Scientific & Commercial Aspects Market Report 2020-2029 with Profiles of 298 Companies Along with 583 Collaborations

Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) — The “Personalized Medicine – Scientific & Commercial Aspects” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering.

The concept of personalized medicine described in this report remains remains the best way to integrate new technologies such as nanobiotechnology for improving healthcare.

Increase in efficacy and safety of treatment by individualizing it has benefits in financial terms. Information is presented to show that personalized medicine will be cost-effective in healthcare systems. For the pharmaceutical companies, segmentation of the market may not leave room for conventional blockbusters but smaller and exclusive markets for personalized medicines would be profitable. Marketing opportunities for such a system are described with market estimates from 2019-2029.

Profiles of 298 companies involved in developing technologies for personalized medicines, along with 583 collaborations are included.
The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics,pharmacoproteomics, and metabolomics.

Basic technologies of molecular diagnostics play an important role, particularly those for single nucleotide polymorphism (SNP) genotyping. Biomarkers play an important role in personalized medicine. Diagnosis is integrated with therapy for selection of treatment as well for monitoring the results. There is emphasis on early detection and prevention of disease in modern medicine. Biochip/microarray technologies and next generation sequencing are also important.

Pharmacogenetics, the study of influence of genetic factors on drug action and metabolism, is used for predicting adverse reactions of drugs. Several enzymes are involved in drug metabolism of which the most important ones are those belonging to the family of cytochrome P450. The knowledge of the effects of polymorphisms of genes for the enzymes is applied in drug discovery and development as well as in clinical use of drugs. Cost-effective methods for genotyping are being developed and it would be desirable to include this information in the patient’s record for the guidance of the physician to individualize the treatment.

Pharmacogenomics, a term that overlaps with pharmacogenetics but is distinct, deals with the application of genomics to drug discovery and development. It involves the mechanism of action of drugs on cells as revealed by gene expression patterns. Pharmacoproteomics is an important contribution to personalized medicine as it is a more functional representation of patient-to-patient variation than that provided by genotyping.A ‘pharmacometabonomic’ approach to personalizing drug treatment is also described.

Biological therapies such as those which use patient’s own cells are considered to be personalized medicines. Vaccines are prepared from individual patient’s tumor cells. Individualized therapeutic strategies using monoclonal bodies can be directed at specific genetic and immunologic targets. Ex vivo gene therapy involves the genetic modification of the patient’s cells in vitro, prior to reimplantation of these cells in the patient’s body.

Various technologies are integrated to develop personalized therapies for specific therapeutic areas described in the report. Examples of

Read More